AXGN - Company ID 0000805928
The table below shows Axogen, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.56M | -$13.18M | -$12.27M | -$7.42M | -$11.05M | -$10.82M |
| Capital expenditure | $2.79M | $256.00K | $924.00K | $4.30M | $5.04M | $3.10M |
| Investing cash flow | -$15.96M | $1.34M | -$3.25M | -$786.00K | -$7.24M | $870.00K |
| Dividends paid | - | - | - |
Axogen, Inc. reported operating cash flow of $812.00K for fiscal year 2025. That is down 82.1% from $4.54M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$11.24M (FY 2016) to $812.00K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $59.51M | $2.38M | $204.00K | $633.00K | $95.00K | $517.00K |